DE1617319C3 - - Google Patents

Info

Publication number
DE1617319C3
DE1617319C3 DE1617319A DE1617319A DE1617319C3 DE 1617319 C3 DE1617319 C3 DE 1617319C3 DE 1617319 A DE1617319 A DE 1617319A DE 1617319 A DE1617319 A DE 1617319A DE 1617319 C3 DE1617319 C3 DE 1617319C3
Authority
DE
Germany
Prior art keywords
filtered
serum
hours
irradiated
rpm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE1617319A
Other languages
German (de)
English (en)
Other versions
DE1617319A1 (de
DE1617319B2 (enExample
Inventor
Wolfgang Dr.-Chem. 6078 Neu Isenburg Stephan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotest Serum Institut GmbH
Original Assignee
Biotest Serum Institut GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotest Serum Institut GmbH filed Critical Biotest Serum Institut GmbH
Priority to DE19511617319 priority Critical patent/DE1617319A1/de
Priority claimed from DE1966B0089704 external-priority patent/DE1617335B2/de
Publication of DE1617319A1 publication Critical patent/DE1617319A1/de
Publication of DE1617319B2 publication Critical patent/DE1617319B2/de
Application granted granted Critical
Publication of DE1617319C3 publication Critical patent/DE1617319C3/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE19511617319 1951-01-28 1951-01-28 Verfahren zur Herstellung von stabilem,hepatitisfreiem Serum Granted DE1617319A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19511617319 DE1617319A1 (de) 1951-01-28 1951-01-28 Verfahren zur Herstellung von stabilem,hepatitisfreiem Serum

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19511617319 DE1617319A1 (de) 1951-01-28 1951-01-28 Verfahren zur Herstellung von stabilem,hepatitisfreiem Serum
DEB0086560 1966-04-06
DE1966B0089704 DE1617335B2 (de) 1966-11-05 1966-11-05 Verfahren zur herstellung von lipoproteinfreiem, stabilem und sterilem serum
DEB0091011 1967-02-02

Publications (3)

Publication Number Publication Date
DE1617319A1 DE1617319A1 (de) 1971-02-11
DE1617319B2 DE1617319B2 (enExample) 1973-09-13
DE1617319C3 true DE1617319C3 (enExample) 1974-05-02

Family

ID=27430606

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19511617319 Granted DE1617319A1 (de) 1951-01-28 1951-01-28 Verfahren zur Herstellung von stabilem,hepatitisfreiem Serum

Country Status (1)

Country Link
DE (1) DE1617319A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264471A (en) * 1979-06-04 1981-04-28 E. I. Du Pont De Nemours And Company Serum and plasma clarification process
EP0679405A1 (de) * 1994-04-25 1995-11-02 Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk Verfahren zur Abtrennung von Viren aus Proteinlösungen

Also Published As

Publication number Publication date
DE1617319A1 (de) 1971-02-11
DE1617319B2 (enExample) 1973-09-13

Similar Documents

Publication Publication Date Title
AT392905B (de) Verfahren zur behandlung eines blutgerinnungsfaktors viii-konzentrats
DE3033932C2 (de) Verfahren zur Kaltsterilisation von Blutgerinnungsfaktor VIII enthaltenden Präparaten
DE3927111C3 (de) Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
CH644520A5 (de) Verfahren zur herstellung eines die proliferation und differenzierung menschlicher granulopoetischer stammzellen stimulierenden faktors.
EP0311950A2 (de) Verfahren zur Herstellung einer sterilen Plasmaproteinlösung, die Fibrinogen und den Gerinnungsfaktor XIII enthält
DE3733181C1 (de) Verfahren zur Herstellung eines hochreinen,virussicheren,biologisch aktiven Transferrinpraeparates
DE1792600A1 (de) Impfstoff und Verfahren zur Herstellung
EP0307002A1 (de) Verfahren zur Herstellung eines Antithrombin III-Konzentrates
EP0679405A1 (de) Verfahren zur Abtrennung von Viren aus Proteinlösungen
WO1990005140A1 (de) Verfahren zur herstelung eines hochreinen, nicht infektiösen antihämophiliefaktors mittels chromatographie
DE1617319B2 (enExample)
AT402789B (de) Pharmazeutische präparation auf basis von plasmaproteinen
DE69727736T2 (de) Verfahren zur Aktivierung von Prothrombin zu Thrombin
DE69032375T2 (de) Verfahren zur herstellung von lysozymdimeren
CH637824A5 (de) Kosmetisches mittel auf basis von kollagen und verfahren zu dessen herstellung.
EP0265548B1 (de) Verfahren zur Herstellung von keimabgetöteten oder in ihrer Virulenz abgeschwächten Substanzen sowie deren Verwendung
DE539018C (de) Verfahren zur Herstellung lokal immunisierend wirkender Stoffe aus Bakterien (Staphylokokken, Streptokokken, Bacterium coli)
DE1617335C3 (de) Verfahren zur Herstellung von lipoproteinfreiem, stabilem und sterilem Serum
DE1003398B (de) Verfahren zur Herstellung von Poliomyelitis-Virus-Vaccine
EP0230956B1 (de) Verfahren zur Gewinnung und Herstellung eines pasteurisierten Präparates von alpha2-Antiplasmin
DE462254C (de) Verfahren zur Herstellung von Reinkultur - Trockenpraeparaten
DE663748C (de) Verfahren zur Herstellung eines wirksamen Mittels zur Zersetzung von koerperfremdem Eiweiss, insbesondere fuer Krebserkrankungen
AT376883B (de) Verfahren zur inaktivierung von vermehrungsfaehigen krankheitserregern
DE847647C (de) Verfahren zur Herstellung von Heilmitteln gegen pathogene Mikroben
DE945948C (de) Verfahren zur Herstellung eines Poliomyelitis-Vaccine

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
E77 Valid patent as to the heymanns-index 1977
8339 Ceased/non-payment of the annual fee